Tomuzotuximab (Anti-ERBB1 / EGFR / HER1)

Tomuzotuximab (Anti-ERBB1 / EGFR / HER1) is a fully human glycoengineered IgG1 monoclonal antibodytargeting EGFR. It has anticancer effects. MW :150 KD.

Trivial name Anti-Human EGFR Recombinant Antibody
Catalog Number A3080
CAS# 1646321-00-7
Size 1mg*5